imux.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
Disallow: /wp-content/uploads/wpforms/ # START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://imux.com/sitemap_index.xml # --------------------------- # END YOAST
Meta Tags
Title Home - Immunic
Description Latest Immunic is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune
Keywords N/A
Server Information
WebSite imux faviconimux.com
Host IP 91.203.110.225
Location Germany
Related Websites
Site Rank
More to Explore
imux.com Valuation
US$9,972,200
Last updated: 2023-05-08 16:12:24

imux.com has Semrush global rank of 1,061,381. imux.com has an estimated worth of US$ 9,972,200, based on its estimated Ads revenue. imux.com receives approximately 1,150,639 unique visitors each day. Its web server is located in Germany, with IP address 91.203.110.225. According to SiteAdvisor, imux.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$9,972,200
Daily Ads Revenue US$9,206
Monthly Ads Revenue US$276,154
Yearly Ads Revenue US$3,313,839
Daily Unique Visitors 76,710
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
imux.com. A 3599 IP: 91.203.110.225
imux.com. NS 43200 NS Record: pns.dtag.de.
imux.com. NS 43200 NS Record: secondary007.dtag.net.
imux.com. MX 3600 MX Record: 10 imux-com.mail.protection.outlook.com.
imux.com. TXT 3600 TXT Record: v=spf1 include:spf.protection.outlook.com -all
imux.com. TXT 3600 TXT Record: docusign=b99bb46b-f2dd-47e2-80bf-38554487b72a
HtmlToTextCheckTime:2023-05-08 16:12:24
Scroll to top About Pipeline Home About Management Board of Directors Scientific-Medical Advisory Board Company Values Pipeline Vidofludimus Calcium IMU-856 News Publications Investors IR Home News Releases Events and Presentations Stock Information Financials and SEC Filings Corporate Governance IR Contact Career Contact © 2023, Immunic Therapeutics All rights reserved. Home About Management Board of Directors Scientific-Medical Advisory Board Company Values Pipeline Vidofludimus Calcium IMU-856 News Publications Investors IR Home News Releases Events and Presentations Stock Information Financials and SEC Filings Corporate Governance IR Contact Career Contact Search for Immunic is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. Developing Selective Oral Drugs in Immunology Immunic Therapeutics Immunic is developing orally administered, small molecule programs, each of which has
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Sat, 30 Oct 2021 08:40:55 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Location: https://imux.com/

HTTP/2 200 
server: nginx
date: Sat, 30 Oct 2021 08:40:56 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
imux.com Whois Information
Domain Name: IMUX.COM
Registry Domain ID: 84564820_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.registrar.telekom.de
Registrar URL: http://www.registrar.telekom.de
Updated Date: 2020-11-16T02:30:50Z
Creation Date: 2002-03-17T01:11:25Z
Registry Expiry Date: 2023-03-17T00:11:25Z
Registrar: Deutsche Telekom AG
Registrar IANA ID: 226
Domain Status: ok https://icann.org/epp#ok
Name Server: PNS.DTAG.DE
Name Server: SECONDARY007.DTAG.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-17T19:16:16Z <<<

Copyright © 2022 WebZZ.US 0.0268